Reuters logo
BRIEF-Diplomat Pharmacy says Nerlynx tablets for HER2+ breast cancer in the extended adjuvant setting
July 20, 2017 / 8:40 PM / 3 months ago

BRIEF-Diplomat Pharmacy says Nerlynx tablets for HER2+ breast cancer in the extended adjuvant setting

July 20 (Reuters) - Diplomat Pharmacy Inc

* Nerlynx™ (neratinib) tablets for HER2+ breast cancer in the extended adjuvant setting

* Has been selected to be in limited distribution network for Puma Biotechnology’s new product, Nerlynx

* Diplomat Pharmacy - Nerlynx is indicated for extended adjuvant treatment of adult patients with early-stage HER2 overexpressed/amplified breast cancer Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below